 |
|
|
January 20, 2012
Committee for Orphan Medicinal Products Recommends Orphan Designation for Biodel’s Stabilized Glucagon for the Treatment of Congenital Hyperinsulinism
|
|
|
January 19, 2012
Complete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing
|
|
|
January 17, 2012
Roka Bioscience Awarded AOAC-RI Certification for Roka Listeria Detection Assay
|
|
|
January 11, 2012
Three Adimab Antibodies Enter Human Clinical Trials
|
|
|
January 09, 2012
Complete Genomics Announces Shipment of Approximately 3,000 Genomes in 2011
|
|
|
January 06, 2012
Roka Bioscience Secures $47.5 Million In Series D Financing
|
|
|
January 05, 2012
GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor, CCX354, for theTreatment of Rheumatoid Arthritis
|
|
|
January 04, 2012
MethylGene Announces the Appointment of Rachel Humphrey, MD as Executive Vice President and Chief Medical Officer
|
|
|
December 28, 2011
Alexion to Acquire Enobia Pharma Corp. and First Potential Treatment for Patients with Hypophosphatasia (HPP)
|
|
|
December 23, 2011
Acceleron Secures $30M Private Financing
|
|
|
View archive |
|
|
